Literature DB >> 33630020

Removing One Barrier to Opioid Use Disorder Treatment: Is It Enough?

Melissa B Weimer1, Sarah E Wakeman2, Richard Saitz3,4.   

Abstract

Mesh:

Substances:

Year:  2021        PMID: 33630020     DOI: 10.1001/jama.2021.0958

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  6 in total

1.  Population-based estimates of geographic accessibility of medication for opioid use disorder by substance use disorder treatment facilities from 2014 to 2020.

Authors:  Jonathan Cantor; David Powell; Aaron Kofner; Bradley D Stein
Journal:  Drug Alcohol Depend       Date:  2021-09-27       Impact factor: 4.492

2.  Adjunct interventions to standard medical management of buprenorphine in outpatient settings: A systematic review of the evidence.

Authors:  Jessica J Wyse; Benjamin J Morasco; Jacob Dougherty; Beau Edwards; Devan Kansagara; Adam J Gordon; P Todd Korthuis; Anaïs Tuepker; Stephan Lindner; Katherine Mackey; Beth Williams; Anders Herreid-O'Neill; Robin Paynter; Travis I Lovejoy
Journal:  Drug Alcohol Depend       Date:  2021-07-29       Impact factor: 4.852

3.  X-Waiver Exemption in the Treatment of Opioid Use Disorder.

Authors:  Riley D Shearer; Becky R Ford; Benjamin A Howell
Journal:  JAMA       Date:  2021-08-03       Impact factor: 157.335

4.  Discordance in Addressing Opioid Crisis in Rural Communities: Patient and Provider Perspectives.

Authors:  Bonyan Qudah; Martha A Maurer; David A Mott; Michelle A Chui
Journal:  Pharmacy (Basel)       Date:  2022-07-27

5.  Improve Access to Care for Opioid Use Disorder: A Call to Eliminate the X-Waiver Requirement Now.

Authors:  Gail D'Onofrio; Edward R Melnick; Kathryn F Hawk
Journal:  Ann Emerg Med       Date:  2021-05-07       Impact factor: 5.721

6.  The impact of CARA mandates on nurse practitioner controlled substance prescribing in Oregon: a cohort study.

Authors:  Tracy A Klein; Daniel Hartung; Sheila Markwardt
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-01-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.